031 – Sangamo woes

Today, I talk about Sangamo’s updated data from their talks at the WORLDSymposium. We saw updates on their MPSI and MPSII programs that the market responded to with big selling.

I refer to their pre-clinical data and see how it compares to the updated human data. I finish up by giving my predictions and what I’m watching this week.

Relevant links:

*This is not investment advice*


Leave a Reply

%d bloggers like this: